Bacterial compounds induce the production of reactive oxygen species (ROS) in meningitis. Rifampin releases smaller quantities of proinflammatory compounds from Streptococcus pneumoniae than do b-lactam antibiotics. Therefore, rabbits infected intracisternally with S. pneumoniae were treated intravenously either with rifampin 5 mg/kg/h or ceftriaxone 10 mg/kg/h ( each). Before initiation of antibiotic treatment, a strong positive correlation between n = 9 ROS production of cerebrospinal fluid (CSF) phagocyte populations and bacterial CSF titers was observed (granulocytes: , ; monocytes: , ). CSF leukocytes r = .90 P ! .0001 r = .81 P ! .0001 s s from rifampin-treated rabbits produced less ROS (monocytes at 2 h after initiation of treatment:
s s from rifampin-treated rabbits produced less ROS (monocytes at 2 h after initiation of treatment:
; at 5 h: ; granulocytes at 5 h: ) than did leukocytes from animals P = .045 P = .014 P = .036 receiving ceftriaxone. The CSF malondialdehyde concentrations and the density of apoptotic neurons in the dentate gyrus were lower in rifampin-than in ceftriaxone-treated animals ( and .005). The use of rifampin to reduce the release of ROS and to decrease secondary P = .002 brain injury appears promising.
An intense inflammatory reaction of the host is considered to be one cause of secondary brain damage in meningitis. Reactive oxygen species (ROS) released into the central nervous compartments during inflammation are of dual character. Although essential for the inactivation of pathogens, they can also cause injury to the host. ROS can inactivate a variety of enzymes and ion transporters and induce lipid peroxidation with consecutive release of peroxidation byproducts and may trigger DNA cleavage. This may eventually result in loss of membrane function, DNA damage, and cell death [1, 2] .
In meningitis, bacterial lysis by b-lactam antibiotics causes a burst of meningeal inflammation immediately after the initiation of antibiotic therapy [3, 4] . This is due to the release of proinflammatory components of the bacterial cell wall (peptidoglycans, teichoic [TA] and lipoteichoic acids [LTA] , and endotoxin) into the cerebrospinal fluid (CSF) [3, [5] [6] [7] . The in-flammatory host response after the initiation of therapy with antibiotics currently used for meningitis may contribute to early mortality and long-term sequelae in bacterial meningitis. Antibiotics that act by inhibiting protein synthesis, such as rifamycins, release smaller quantities of LTA/TA than do b-lactam antibiotics both in vitro and in vivo [6, 7] . Rifampin, as compared with ceftriaxone, reduced early mortality in a mouse model of Streptococcus pneumoniae meningitis [7] .
For these reasons, we compared the effect of rifampin versus ceftriaxone on ROS production of CSF phagocytes, on CSF malondialdehyde (MDA) concentrations, and on neuronal damage in a rabbit model of pneumococcal meningitis.
Materials and Methods

Model of meningitis.
After intramuscular induction of anesthesia with ketamine (25 mg/kg) and xylazine (5 mg/kg), 18 New Zealand White rabbits (weight ∼2.5 kg) were inoculated intracisternally with 10 6 colony-forming units (CFU) of a S. pneumoniae type 3 strain [4] . Anesthesia was maintained by intravenous urethane for the entire duration of the experiment (24 h).
Experimental protocol. Antibiotic treatment was started 16 h after infection, either with ceftriaxone (Rocephin, HoffmannLaRoche, Grenzach-Wyhlen, Germany;
; 20 mg/kg intraven = 9 nously loading, 10 mg/kg/h maintenance dose) or rifampin (Rifa, Grü nenthal, Stolberg, Germany;
; 10 mg/kg intravenously n = 9 loading, 5 mg/kg/h maintenance dose).
CSF (0.3 mL) was drawn by intracisternal puncture at 16, 18, 21, and 24 h after infection. Leukocyte densities and pneumococcal CSF titers were determined [4] . Bacterial titers at 16, 18, 21, and 24 h served for log-linear regression analysis (log CFU/mL/h). The remaining CSF was immediately centrifuged at 250 g for 10 min to isolate the leukocyte pellet (1). Supernatant (1) was centrifuged a second time at 3000 g for 10 min, and supernatant (2) was stored at Ϫ70ЊC for protein, lactate, rifampin, ceftriaxone, and MDA determination. Pellet (2) was discarded. CSF protein content and lactate were determined by colorimetric assays (BCA-proteinTest, Pierce, Rockford, IL; Greiner, Flacht, Germany). Antibiotic CSF concentrations were determined by bioassay in Mueller-Hinton agar using Bacillus subtilis ATCC 6633 spores (Difco, Detroit; rifampin) and Escherichia coli ATCC 25922 (ceftriaxone). Standard curves were constructed in drug-free 1 : 20 diluted rabbit serum.
Detection of ROS. ROS production of CSF phagocytes was measured by flow cytometry using an EPICS cytometer and XL-2 software (Coulter Immunotech, Miami, FL) with linearly amplified forward scatter (FS) and side scatter (SS) and logarithmically amplified fluorescence. Intracellular H 2 O 2 , serving as a prototype of ROS, oxidizes dihydrorhodamine 123 (DHR 123) into the green fluorescent rhodamine 123. Polymorphonuclear leukocytes (PMNs) and monocytes (MNs) were analyzed (1) untreated for spontaneous ROS production, (2) after in vitro stimulation with N-formyl-l-methionyl-l-leucyl-l-phenyalanine (FMLP), a chemotactic peptide, for physiological stimulation, and (3) after exposure to 12-O-tetradecanoylphorbol-13-acetate (TPA), a protein kinase C activator, for maximum stimulation. Because of a shift of the leukocyte populations in the light scattergram caused by FMLP, MNs could not be analyzed after FMLP stimulation.
Within 10 min of CSF removal, pellet (1) containing the CSF leukocytes was resuspended in 3 mL PBS (Sigma, St. Louis) supplemented with 10% fetal calf serum (FCS). Three 1-mL aliquots were prewarmed at 37ЊC for 10 min. Then, 10 mL of 10 Ϫ4 M DHR 123 (Molecular Probes, Eugene, OR), stock solution of 1.1 mM in dimethylformamide (DMF; Merck, Darmstadt, Germany), were added to all 3 tubes. Ten microliters of 10 Ϫ5 M TPA (Sigma), stock solution of 1 mM in DMF, were added to tube 3, and incubation was continued at 37ЊC for 10 min. Ten microliters of 10 Ϫ5 M FMLP (Sigma), stock solution of 1 mM in DMF, were added to tube 2, and incubation was continued at 37ЊC for 15 min. Thereafter, samples were kept on ice until injection into the flow cytometer. CSF phagocyte populations were physically gated in the light scattergram and analyzed for rhodamine 123 fluorescence. The decadic logarithm of the mean fluorescence intensity (log mean FLi) of the measured events in the gate, which depends on the H 2 O 2 content of the individual cells measured, was used to determine ROS production in a semiquantitative manner [8] . The flow cytometric study of the leukocytes, including the stimulation experiments, was completed within 90 min of removal of CSF.
Determination of MDA CSF concentration. The total MDA concentration of pooled 21-h and 24-h CSF samples was determined by high-pressure liquid chromatography (J. Pilz, I. Meineke, and C. H. Gleiter, unpublished data). Fifty microliters of CSF, 5 mL of 1% EDTA, and 10 mL of 6 N NaOH were incubated for 30 min at 60ЊC. The hydrolyzed samples were acidified with 25 mL 35 % (v/v) perchloric acid. After centrifugation, 50 mL of the supernatants were incubated with 5 mL 5 mM 2,4-dinitrophenylhydrazine (DNPH) solution for 10 min. Thirty microliters of the derivatized samples were injected onto the HPLC system. The MDA DNPH derivative was separated from interfering compounds at 30ЊC on a reversed-phase column (Nucleosil C18 mm, 3 mm particle 3 ϫ 125 size, SepServ, Berlin, Germany; mobile phase 38% acetonitrile, 61.8 % water, 0.2 % [v/v] acetic acid, flow rate 0.6 mL/min) and quantified with an UV detector at 310 nm. Peak areas were compared with the peak areas of the MDA standard curve (10, 5, 2.5, 1.25, and 0.625 nmol/mL) with a Merck D 2000 Chromato-Integrator (Merck).
Detection of apoptosis. Rabbits were sacrificed by intravenous injection of 75 mg thiopental (Trapanal, Byk Gulden, Konstanz, Germany). One-micrometer sections containing the hippocampal formation were stained with hematoxylin and eosin (HE) and by in situ tailing to visualize DNA fragmentation. The number of apoptotic neurons per mm 2 of dentate granular cell layer was quantified [9] .
Statistics. Data were expressed as . Unpaired 2-mean ‫ע‬ SD tailed t test was performed for the comparison between rifampinand ceftriaxone-treated animals and paired 2-tailed t test for the detection of changes within one group during the course of the experiment and for stimulation experiments. The correlation between CSF leukocyte densities, bacterial titers, and ROS production before antibiotic treatment was studied by Spearman rank correlation. A P value !.05 was considered significant. and MNs from rifampin-treated rabbits showed a decreased ROS production, compared with leukocytes from ceftriaxonetreated animals (PMN ; MN ; figure 1A, 1B). P = .036 P = .014 In comparison with the pretreatment ROS production (16 h), PMNs from rifampin-treated animals produced significantly less ROS at 21 ( ) and 24 h ( ). In contrast, in P = .017 P = .024 PMNs from ceftriaxone-treated animals the ROS production significantly fell below the pretreatment level only at 24 h ( ; figure 1A) . P = .023
Results
Rifampin
Prior to antibiotic treatment, FMLP failed to stimulate PMN ROS production substantially. Once antibiotic treatment was started, FMLP stimulated the PMNs of rifampin-treated animals at 18 ( ), 21 ( ), and 24 h ( ) after P = .048 P = .002 P = .0002 infection. In ceftriaxone-treated animals, FMLP stimulated PMN ROS production only at 21 ( ) and 24 h ( P = .016 P = ; table 1). TPA increased ROS production of both phag-.0016 ocyte populations at all times.
The total MDA concentrations in CSF and the densities of apoptotic neurons in the dentate gyrus of the hippocampal formation were substantially lower in rifampin-than in ceftriaxone-treated animals ( and .005; table 1). P = .002
Discussion
ROSs are considered key mediators in the pathophysiology of bacterial meningitis [1, 2] . In a well-characterized rabbit model of S. pneumoniae meningitis, the present study demonstrates a significant attenuation of ROS production by CSF phagocytes, a lower CSF MDA concentration, and a reduced density of apoptotic neurons in the dentate gyrus after rifampin treatment in comparison to the standard therapy with ceftriaxone.
PMNs, MNs, and cerebrovascular endothelial cells, but not astrocytes and neurons, generate ROS on stimulation with S. pneumoniae [1, 2, 10] . In meningitis, the major portion of ROS is produced by leukocytes, in particular by PMNs [2] . Therefore, flow cytometry in the CSF can be used to study ROS production in bacterial meningitis. Assessment of ROS production by the rhodamine 123 technique is established for blood and CSF phagocytes [8, 11] . The method allows semiquantitative measurement of the cell-specific functional stimulation in a defined compartment. The CSF MDA concentration is an indicator of overall lipid peroxidation. It is strongly elevated in patients with bacterial meningitis, compared with patients with viral meningitis and noninflammatory neurological disorders [10] . Lipid peroxidation is one major mechanism linking ROS production and neuronal damage in bacterial meningitis [1, 2] .
In the present study, prior to antibiotic treatment, the oxidative burst activity of CSF phagocytes mainly depended on the bacterial CSF titers. This agrees well with the ability of bacterial products to directly stimulate ROS production in PMNs, MNs, and endothelial cells [10] . Initiation of antibiotic treatment with ceftriaxone resulted in a small increase of the oxidative burst activity of CSF phagocytes, whereas rifampin therapy immediately led to a slight decrease of the oxidative activity of the CSF leukocytes (figure 1). Statistically significant differences in the ROS production of leukocytes during therapy with rifampin and ceftriaxone, respectively, were noted 5 (PMNs and MNs) and 2 h (MNs) after initiation of antibiosis. Stimulation experiments also suggested a lower functional ac-tivation of granulocytes during rifampin treatment: PMNs from rifampin-treated rabbits showed an earlier return of inducibility of ROS production by FMLP than PMNs from ceftriaxonetreated animals.
In addition to ROS, excitatory amino acids, especially glutamate [12, 13] , appear to be involved in the generation of neuronal damage in bacterial meningitis. Oxidative injury and excitotoxicity are closely linked [14] . Both mechanisms may potentiate each other in bacterial meningitis. In animal studies, several radical scavengers attenuated early pathophysiological changes in bacterial meningitis [1] . Adjuvant therapy with aphenyl-tert-butyl nitrone strongly reduced neuronal injury in the neocortex and hippocampal formation in experimental Streptococcus group B meningitis [2] . None of these approaches, however, was evaluated as an adjunct to antibiotic therapy in human bacterial meningitis.
Rifampin as an established antibacterial agent could close the gap between experimental and clinical neuroprotective approaches. The reduction of the release of proinflammatory bacterial compounds by rifampin [6, 7] decreases ROS production of CSF phagocytes and endothelial cells, reduces lipid peroxidation, and attenuates neuronal damage. The rapid induction of resistance to rifampin during monotherapy precludes its use as a single agent for S. pneumoniae meningitis. Nevertheless, no substantial release of LTA/TA was observed in vitro, when ceftriaxone was added 6 h after initiation of antibiotic therapy with rifampin [15] . Therefore, after initial rifampin therapy, blactam antibiotics may be added, when the majority of bacteria has already been killed by rifampin (i.e., 12-24 h later). The use of rifampin as an initial therapy for bacterial meningitis has as yet not been studied in humans. It would be dangerous to adapt this approach in clinical practice without first conducting an appropriately controlled clinical trial.
In conclusion, this study provides further evidence for the concept that minimizing the release of proinflammatory bacterial compounds may improve outcome in bacterial meningitis and, perhaps, other life-threatening infections. The measurement of ROS production of leukocytes by flow cytometry is a novel approach to study the intensity of the oxidative burst in the infected compartment.
